Saturday, July 12, 2025

Latest

Cannabis SPAC Relativity Acquisition Prices US$125 Million IPO

Special purpose acquisition company Relativity Acquisition Corp. (Nasdaq: RACYU) started trading its securities on the Nasdaq Global Market today. The firm priced its initial public offering, aiming to raise total proceeds of US$125.0 million.

The offering will entail selling 12.5 million units priced at US$10.00 per unit. Each unit is composed of one Class A common share and one whole warrant exercisable to purchase one common share at US$11.50 per share.

The company units trade on the Nasdaq big board under the symbol “RACYU”. Once the securities separate, the company shares and warrants will trade under the ticker symbols “RACY” and “RACYW”, respectively.

The proposed offering is being managed by Alliance Global Partners as the sole bookrunner. The underwriters were granted a 45-day over-allotment option to purchase additional 1.875 million company units.

The blank check company is led by its chairman and CEO Tarek Tabsh, the co-founder of the pharmaceutical firm Oxford Cannabinoid Technologies. The firm said that it intends to focus its business combination search in the legalized cannabis industry.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Shein Files For IPO, Recently Valued At $66 Billion

Shein, the globally recognized online fashion company founded in China, has confidentially filed for an...

Tuesday, November 28, 2023, 07:44:12 AM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO)...

Friday, May 6, 2022, 02:24:00 PM

Venture Capital-Backed SPAC Banner Acquisition Eyes US$150 Million IPO

Special purpose acquisition company Banner Acquisition Corp. (Nasdaq: BNNRU) started trading publicly yesterday on the...

Thursday, September 9, 2021, 12:44:00 PM